Last quarter (Q ), ViaDerma's total revenue was $5.82M, an increase of 0.19% from the same quarter last year. In Q, ViaDerma's net income was $954.83K. See ViaDerma’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 11	Dec 10	Dec 09	Dec 08	Dec 07
Total Revenue	$ 17.80M	$ 19.01M	$ 26.83M	$ 25.26M	$ 25.67M	$ 17.96K
Cost of Revenue	$ 12.66M	$ 13.35M	$ 16.68M	$ 14.28M	$ 15.11M	-
Gross Profit	$ 5.14M	$ 5.66M	$ 10.15M	$ 10.98M	$ 10.56M	-
Operating Expense	$ 1.40M	$ 1.62M	$ 2.38M	$ 4.59M	$ 1.55M	$ 159.44K
Operating Income	$ 3.74M	$ 4.04M	$ 7.77M	$ 6.39M	$ 9.01M	$ -141.48K
Net Non Operating Interest Income Expense	$ -660.62K	$ -489.89K	$ -1.26M	$ -327.84K	$ -292.71K	-
Other Income Expense	-	$ -1.54K	$ -1.43K	-	-	-
Pretax Income	$ 3.08M	$ 3.55M	$ 6.50M	$ 6.07M	$ 8.72M	-
Tax Provision	$ 767.00K	$ 874.34K	$ 1.99M	$ 1.97M	$ 2.16M	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ 2.31M	$ 2.67M	$ 4.51M	$ 4.09M	$ 6.55M	$ -141.48K
Basic EPS	$ 17.00	$ 19.50	$ 33.00	$ 30.00	$ 49.50	$ -12.60
Diluted EPS	$ 17.00	$ 19.50	$ 33.00	$ 30.00	$ 49.50	$ -12.60
Basic Average Shares	$ 549.29K	$ 137.32K	$ 137.32K	$ 135.05K	$ 133.33K	$ 11.38K
Diluted Average Shares	$ 549.29K	$ 137.32K	$ 137.32K	$ 138.37K	$ 133.33K	$ 11.38K
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 14.06M	$ 14.97M	$ 19.06M	$ 18.87M	$ 16.66M	$ 159.44K
Net Income From Continuing And Discontinued Operation	$ 2.31M	$ 2.67M	$ 4.51M	$ 4.09M	$ 6.55M	$ -141.48K
Normalized Income	$ 2.31M	$ 2.67M	$ 4.51M	$ 4.09M	$ 6.55M	$ -141.48K
Interest Expense	$ 675.30K	$ 502.36K	$ 1.27M	$ 329.57K	$ 295.70K	-
EBIT	$ 3.75M	$ 4.05M	$ 7.77M	$ 6.40M	$ 9.01M	$ -141.48K
EBITDA	$ 6.85M	$ 6.86M	$ 9.33M	$ 7.05M	$ 9.44M	$ -139.86K

Currency in USD

ViaDerma Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing